(Q24234597)

4

0 references

Matthias Egger

3

0 references

Andrew Anglemyer

1

object named as

Andrew Anglemyer

0 references

author name string

George W Rutherford

Cochrane Database of Systematic Reviews

2

0 references

publication date

11 May 2011

0 references

published in

0 references

cites work

Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Modified Kigali combined staging predicts risk of mortality in HIV-infected adults in Lusaka, Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

SAVVY® (C31G) Gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Heterosexual HIV-1 transmission and viral load in hemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Treatment to prevent transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Risk factors for recent HIV infection in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Decline in HIV infectivity following the introduction of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153

Persistent HIV RNA shedding in semen despite effective antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009153